Tim Demuth - Global Clin Dev, Merck KGaA

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 82 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Combination of Cinrebafusp Alfa with Ramucirumab and Paclitaxel is Well Tolerated and Elicits Encouraging Clinical Activity in Patients with HER2-positive Gastric/gastroesophageal Junction (GEJ) Adenocarcinoma

Geoffrey Ku,Jeeyun Lee,Kayti Aviano,Tim Demuth, Laura-Carolin Hasenkamp,Shane A. Olwill

CANCER RESEARCHno. 8 (2023)

Cited0Views0Bibtex

Abstract CT154: Combination of Cinrebafusp Alfa with Ramucirumab and Paclitaxel is Well Tolerated and Elicits Encouraging Clinical Activity in Patients with HER2-positive Gastric/gastroesophageal Junction (GEJ) Adenocarcinoma

Geoffrey Ku,Jeeyun Lee,Kayti Aviano,Tim Demuth, Laura-Carolin Hasenkamp,Shane A. Olwill

Cancer Researchno. 8_Supplement (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn